A potential new vaccine for COVID-19. The European Commission approved the contract with Valneva

The agreement approved today allows for the vaccine to be adapted to new variants. Our wide range of vaccines will help us In the fight against Covid disease and its variants in Europe and abroad. The epidemic is not over yet. Anyone can get vaccinated – commented the President of the European Commission Ursula von der Leyen.

So far, the European Commission has concluded contracts with companies to produce vaccines in Europe AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna i Novavax.

Valniva is a French biotechnology company that is developing an inactivated virus vaccine, which is produced from live virus by chemical inhibition.

“It is a traditional vaccination technology that has been used for 60-70 years, with established methodology and a high level of safety. Most influenza vaccines and many primary vaccines use this technology. It is currently the only potential inactivated vaccine in clinical trials against Covid-19 in Europe”- The European Commission announced in a press release.